PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34130704-0	2021	Retraction Note to: Differential modulatory effects of GSK-3b and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma.	Sorafenib	74-83	MDM2 proto-oncogene	Homo sapiens	66-70	
27688096-7	2016	Together, these results suggest that miR-367-3p may function as an AR enhancer to increase Sorafenib chemotherapy efficacy via altering the MDM2/AR/FKBP5/PHLPP/(pAKT and pERK) signals to better suppress HCC metastasis.	Sorafenib	91-100	MDM2 proto-oncogene	Homo sapiens	140-144	
21929745-0	2011	Differential modulatory effects of GSK-3beta and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma.	Sorafenib	57-66	MDM2 proto-oncogene	Homo sapiens	49-53	
21929745-13	2011	The data suggest that the ability of sorafenib to activate GSK-3beta and alter the intracellular distribution of p53 may be exploitable as an adjunct to agents that prevent the HDM2-dependent degradation of p53 in the treatment of melanoma.	Sorafenib	37-46	MDM2 proto-oncogene	Homo sapiens	177-181